March 09 2020
Like so many, NRG Oncology leadership is tracking closely with developments related to the spread of the COVID-19, or Coronavirus. Many of our Member Institutions have enacted travel bans and other initiatives aimed at reducing the risk of exposure. In line with the current recommendations, NRG Oncology has ceased any international travel – an activity impacting our Audit Program, and continues to assess the ever changing status and recommendations. We are respecting our Member Site’s current restrictions and ensuring we are doing all we can support the continuing good health and wellness of our staff and others working on our behalf. We welcome related updates from our Members, and can address any queries through our Executive Director, Kati Stoermer (
stoermerk@nrgoncology.org or 412-697-6640) If you have questions specific to an upcoming Audit, please contact the Mimi Passarello (
passarellom@nrgoncology.org or 412-383-2189.